AzTrials
AzTrials

Osteoporotic FracturesNCT03484208

Evaluation of a Fracture Liaison Service in the Osteoporosis Care

An observational study of Osteoporotic Fractures, run by Fondation Hôpital Saint-Joseph at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The St JOSEPH'S HOSPITAL set up a fracture liaison service for osteopotic fracture. A specific nurse screens eligible patient admitted in emergency yard and call them to propose a bone densitometry and a medical coverage.. The aim of the study is to evaluate this new organisation Read more about this study

Who is it for?
Ages 45 to 95 years
Conditions the study is for
Osteoporotic Fractures
What is being tested?
osteoporotic fracture liaison service
How many people
346 participants
Where
1 siteFrance
Study dates
8 Feb 2018to 26 Apr 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 95 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients admitted in emergency yard for low energy fracture

Who may be able to join

  • Age between 45 and 95 years old.
  • Admitted in emergency yard for law energy trauma

Who cannot join

  • feet fracture
  • fracture on prothesis
  • patient transferred elsewhere
  • homeless people
  • patient with lot of comorbidities

Trial locations and contacts

1 site in 1 country.

France1 site
  • Groupe Hospitalier Paris Saint Joseph

    Paris, Île-de-France Region, 75014

Other trials in France

About this study

The St JOSEPH'S HOSPITAL set up a fracture liaison service for osteopotic fracture. A specific nurse screens eligible patient admitted in emergency yard and call them to propose a bone densitometry and a medical coverage..

The aim of the study is to evaluate this new organisation

Being tested
osteoporotic fracture liaison service
Medical subject headings
Osteoporotic Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • osteoporotic fracture liaison serviceOther

    a specific nurse calls patient and propose them to follow the osteoporotic fracture liaison service

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. valuable osteoporosis care

    valuable osteoporosis care means a bone densitometry for minor fracture and a medical treatment for major fracture

    Measured: Month 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2018
  2. Study start8 Feb 2018
  3. Primary completion7 Aug 2018
  4. Study completion26 Apr 2023

Why it stopped: PI's choice

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
346 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03484208
Sponsor's protocol ID
FILIERE FRACTURE
Status last verified
Apr 2023
First submitted
25 Mar 2018
Last updated
28 Apr 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Osteoporotic Fractures, run by Fondation Hôpital Saint-Joseph at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 28 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: PI's choice). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

valuable osteoporosis care (time frame: Month 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in